The mean combined comorbidity score was 0.6 and 0.5 points in the liraglutide and basal insulin groups, respectively, while the mean aDCSI score for both groups was 1.8 points and the mean duration of T2DM for both groups was 4.5 years. The gene discussed is INS; the disease is type 2 diabetes mellitus.